RE:RE:Ryu and DM Investment No wet blanket, Mut! Thank you fo offering a response. I'm on the boards of stocks I invest in to have frank, open and serious discussions to add to my own DD. You know you're offering food for thought when there is a response (positive or negative) when you pivot away from the standard narrative.
While not an investor in DM I recognize that the bulk of their revenue currently comes from procuring the covid test devices. I also understand that this revenue is the capital that feeds the growth of AI. The question is, What impact is this having on the DM sp? At what point will AI be able to run on its own merits? At some point in the near or distant future test device sales will go down ...potentially with a negative impact on the sp of DM ...depending on timing. This has much less to do with the quality of the business model and more to do with the contemporary stock trading environment.
As they are so intimately connected in personnel and business I would expect it is in the interests of
the management of DM (again, at least in the short to midterm) to make sure SCRN is running on all cylinders ....there were regulatory reasons DM stayed out of the testing side of the business and thus the evolution of ScreenPro.
Cheers ....and GLTY!!!
MUTDMUTD wrote: ... DM will always be bringing in the tests... Sorry to put a wet blanket on your thought Smokey... IMO anyhow....